The FDA's approval of Alhemo (concizumab-mtci) revolutionizes hemophilia treatment, offering a simpler, subcutaneous injection for better bleed control and patient independence.

In July 2025, Pfizer announced a study to establish baseline prospective efficacy data of current FIX prophylaxis replacement ...

ZUG, Switzerland and BOSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...

Haemophilia is an inherited, rare bleeding disorder in which the blood fails to clot due to a lack or deficiency of clotting ...

Here’s what blood clots are, how they’re typically treated and what they actually feel and look like so you can know when ...

The demand for treatments targeting myeloproliferative disorders is rising sharply, propelled by several key factors that underscore the market's rob ...

Mutations in a single gene, HNF1A, are known to cause MODY3, a rare, early-onset form of diabetes. Smaller-scale mutations in ...

Switching to the extended half-life therapy Elocta, sold in the U.S. as Eloctate, improved control of bleeds among hemophilia ...

Learn how milk thistle supplements can promote liver health, support cardiovascular health, and help manage cholesterol levels with minimal side effects.

The largest observational study of GLP-1 weight-loss drugs suggests their benefits could be wide-ranging, but there are some risks to consider.

Anemia is a condition that develops when your blood lacks enough healthy red blood cells or hemoglobin. Learn more about anemia symptoms, causes, diagnosis, and treatment.

In December 2012, Clinton fainted and suffered a concussion, from a stomach virus and dehydration, resulting in a clot and double vision, during the Congressional hearings on the Benghazi attack ...